Chemical-controlled Activation of Antiviral Myxovirus Resistance Protein 1

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Myxovirus resistance protein 1 (MX1) is an interferon-induced GTPase crucial for cellular defense against influenza A viruses.
• Mouse MX1 is known to interact with influenza ribonucleoprotein complexes (vRNPs) and inhibit viral replication.
• The precise mechanism by which MX1 interferes with vRNP assembly and function remains incompletely understood.

Purpose of the Study:

• To investigate the mechanism of action of mouse MX1 in inhibiting influenza A virus replication.
• To determine whether MX1 disrupts pre-existing vRNPs or prevents new vRNP assembly.
• To characterize a conditionally active mouse MX1 variant for studying its antiviral function.

Main Methods:

• Development of a conditionally active mouse MX1 variant requiring a small molecule drug for activation.
• Activation of the MX1 variant in cells infected with influenza A virus.
• Analysis of MX1's effect on the interaction between viral polymerase basic 2 (PB2) and nucleoprotein (NP) components.
• Assessment of MX1's antiviral activity and vRNP binding.

Main Results:

• The conditionally active MX1 variant exhibited antiviral activity and bound to NP upon activation by a small molecule drug.
• The interaction between PB2 and NP within vRNPs was disrupted within minutes of MX1 activation.
• The findings support a model where activated MX1 targets incoming influenza A vRNPs.

Conclusions:

• Mouse MX1 inhibits influenza A virus by disrupting the PB2-NP interaction, a key step in vRNP function.
• The study provides a tool (conditionally active MX1) to study MX1's antiviral mechanism in real-time.
• Activated MX1 interferes with the integrity and function of influenza A viral ribonucleoprotein complexes.